EU Pharmacovigilance: Implementing Regulation (EU) 2025/1466
EU Pharmacovigilance: Implementing Regulation (EU) 2025/1466
Regulatory Affairs Vigilance Pharma & Biotech
Thursday, 11 September 2025
Almudena del Castillo, Country Manager Spain & Head of Global Vigilance Division at QbD Group
Share
\
\
X (Twitter) 
\
\
LinkedIn 
\
\
WhatsApp 
\
\
Copy link 
\
\
Mail
The European Commission has amended Regulation (EU) No 520/2012 on pharmacovigilance. The update strengthens oversight of outsourced PV activities, clarifies EudraVigilance monitoring, and aligns processes with international data standards (IDMP, MedDRA, Standard Terms).
Play
EU Pharmacovigilance: Implementing Regulation (EU) 2025/1466 | QbD Group
AI-generated audio
1:32
Key updates
PV outsourcing
Contracts must define roles, data exchange, audit/inspection rights, and prohibit onward subcontracting without written consent. Third parties must accept audits and may be inspected by regulators.
Audits
Risk-based audits must cover all PV activities, including subcontracted work.
EudraVigilance
MAHs must monitor EV alongside other sources; authorities must monitor EV continuously. Signals needing further analysis must be confirmed within 30 days.
Data & reports
Updated requirements for ICSR minimum elements, literature references (with DOI), PSURs (RMM implementation/effectiveness), and PASS registration in EMA’s PAS register.
PSMF
Focus only on major/critical deviations, their impact, and resolution.
What does this mean to you?
This amendment closes long-standing operational gaps: it codifies what many inspectors already expect on third-party control, tightens signal management timelines, and pushes convergence with IDMP and robust RMM effectiveness reporting. MAHs should update contracts, refresh audit plans, and adapt SOPs for EV monitoring and reporting.
Changes take effect from 12 February 2026, so preparations should begin now.
Discover more expert content
Previous
Regulatory Affairs
30 Sep 2025
Adoption of Commission Delegated Regulation (EU) 2025/788 amending Delegated Regulation (EU) 2023/2197 as regards the date of application and new revision of MDCG 2024-14
The amendment defers the application of the rules on the assignment of Unique Device Identifiers...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Regulatory Affairs
27 Nov 2025
EC Confirms 4 EUDAMED Modules Fully Functional
This announcement represents a key milestone in the rollout of the MDR/IVDR framework and...
Regulatory Affairs
22 Apr 2024
New MDCG Guidance on Safety Reporting for Performance Studies of In Vitro Diagnostic Medical Devices under EU Regulation 2017/746 Released
On April 15th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance document...
Regulatory Affairs
30 Apr 2024
EU Parliament Passes Groundbreaking Proposal
On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...
Regulatory Affairs
30 Sep 2025
Adoption of Commission Delegated Regulation (EU) 2025/788 amending Delegated Regulation (EU) 2023/2197 as regards the date of application and new revision of MDCG 2024-14
The amendment defers the application of the rules on the assignment of Unique Device Identifiers...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Regulatory Affairs
27 Nov 2025
EC Confirms 4 EUDAMED Modules Fully Functional
This announcement represents a key milestone in the rollout of the MDR/IVDR framework and...
Regulatory Affairs
22 Apr 2024
New MDCG Guidance on Safety Reporting for Performance Studies of In Vitro Diagnostic Medical Devices under EU Regulation 2017/746 Released
On April 15th, 2024, the Medical Device Coordination Group (MDCG) released a new guidance document...
Regulatory Affairs
30 Apr 2024
EU Parliament Passes Groundbreaking Proposal
On April 25th, 2024, the European Parliament approved the proposal made in January 2024 by the...
Regulatory Affairs
30 Sep 2025
Adoption of Commission Delegated Regulation (EU) 2025/788 amending Delegated Regulation (EU) 2023/2197 as regards the date of application and new revision of MDCG 2024-14
The amendment defers the application of the rules on the assignment of Unique Device Identifiers...
Regulatory Affairs
11 Jul 2024
Publication of Amendments to Regulation (EU) 2024/1860
Regulation (EU) 2024/1860 as regards a gradual roll-out of Eudamed, the obligation to inform in...
Next
- 1
- 2
- 3
Stay ahead in life sciences
Keeping up with the fast-paced life sciences industry doesn’t have to be overwhelming.
Our newsletter delivers the latest insights, industry updates, and expert content directly to your inbox, helping you stay informed and make smarter decisions.
Twitter Widget Iframe